Jun
2026
Shanghai New International Expo Center
Visit us
stand E6Q08, Pharma Ingredients
Zone

Hefei Lifeon Pharmaceutical Co., Ltd.

Exhibitor at CPHI & PMEC China 2026
About Us

Founded in 2002,Hefei Lifeon Pharmaceutical Co.Ltd. is a pharmaceutical enterprise integrating drug R&D,production and sales. The company have 4 industrial enterprises ,1 pharmaceutical commercial enterprise,1 pharmaceutical retail chain enterprise. Lifeon postdoctoral workstation had started in 2014. In 2018，FDA has determined that the inspection classification of Hefei Lifeon's facility is "no action indicated"('NAI') lt was successfully listed on the main board of Shenzhen Stock Exchange on December 15, 2020 Our honor: First Prize of Science and Technology in Anhui Province. The legal entity of Anhui Pharmaceutical Profession Association; Chinese chemical pharmaceutical industrial enterprises Comprehensive strength TOP 100. The most investment value enterprise in China's pharmaceutical industry ; Anhui identified by theinnovative pilot enterprises ; Anhui medical Quality Award; The most investment value innovation enterprise in central China.

Read more Show less
Products
Show more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    China
  • On CPHI since:
    2023
  • Certificates:
    2
  • Employees:
    1000 - 4999
Company types
Manufacturer/Innovator
Pharmaceutical company
Primary activities
API Producer
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI & PMEC China 2026
  • 16 Jun 2026 - 18 Jun 2026
  • Shanghai New International Expo Center
  • Visit us at stand E6Q08, Pharma Ingredients

Products Featured at CPHI & PMEC China 2026

  • Prilocaine

    Product Prilocaine

    Prilocaine is an amide local anaesthetic, with anaesthetic intensity and speed similar to that of lidocaine, but with a longer duration and weaker vasodilatory effect. Toxicity is lower than lidocaine. It is used clinically for local anaesthesia, especially for patients who contraindicate the use of epinep...
  • Bempedoic Acid

    Product Bempedoic Acid

    Bempedoic Acid inhibits ATP citrate lyase, acts upstream of HMG-CoA reductase in the cholesterol synthesis pathway, lowers endogenous cholesterol and reduces elevated LDL-C levels by up-regulating the LDL receptor, mitigating muscle-related side effects. Unlike statins, which are currently the mainsta...
  • Methylphenidate Hydrotalcite

    Product Methylphenidate Hydrotalcite

    Methylphenidate hydrochloride is a central excitatory drug that directly excites the respiratory centre of the medulla oblongata and has a milder action. It is mainly used to treat minor disorders of brain function, attention deficit disorder (hyperactivity syndrome in children, etc.), and to eliminate bar...
  • Nifedipine

    Product Nifedipine

    Nifedipine is a dihydropyridine calcium antagonist, which can inhibit the uptake of Ca2+ by myocardium and vascular smooth muscle, dilate coronary arteries, increase coronary artery blood flow, and improve myocardial tolerance to ischemia, and at the same time dilate the small peripheral arteries, reduce p...
  • Paliperidone

    Product Paliperidone

    Paliperidone is an active metabolite of the atypical antipsychotic drug risperidone. Paliperidone is a derivative of benzisoxazole, the active metabolite of risperidone, 9-hydroxy risperidone, a new antipsychotic drug.